MicrobiomePost
Isabelle de Cremoux (Seventure): '2023 Will Be an Excellent Year for Microbiome Research'
Claire Derlot - How Biose Industrie Makes the Difference in LBP Process Development & GMP Production
Herve Affagard - Microbiome ecosystem therapies to improve outcomes for patients with liquid tumours
Clara Desvignes - FMT in USA and EU: how the regulatory landscape is evolving
Christopher Reyes - Bloom Science plans to develop microbial treatment for epilepsy
Tim Sharpington - Strategise how to best approach investors on the research of microbiome
Shaharam Lavasani - The link between gut microbiome and neurodegenerative diseases
Colette Shortt - Pharma vs food: regulatory variations
Gabriel Leventhal - NicheMap: a platform to decipher the interactions that shape microbiomes
Yvonne Nyavor - Improving analysis methods for Live Biotherapeutics Products
Patrice Cani - The role of Akkermansia muciniphila in the gut barrier
From bench to clinic: Faecalibacterium prausnitzii is just around the corner
The IPA Track Day: take home message from the 11th Probiotics, Prebiotics & New foods Congress
IPA Europe, regulatory, scientific and consumer perspective on probiotics
Amandine Brochot - Akkermansia muciniphila: 'How we developed the first next generation probiotic’
Nicola Segata presents ‘Microbiome VIF’
Franco Vicariotto - Probiotics Prebiotics & New Foods 2021
Probiotics Prebiotics & New Foods 2021
Marco Pignatti - The Gut-Skin: an oral probiotic complex solution to support skin distresses
Franco Vicariotto - Innovative probiotic solutions in gynecology
Christophe Lacroix - ‘Our challenge is to culture anaerobic bacteria’
Massimo Marzorati - ProDigest
Sridhar Mani - The Gut Microbiota: An Emerging Player in Breast Cancer
Rémy Burcelin - Gut dysbiosis, metabolic diseases and cancer
Arne Materna - Unlocking the Microbiome: The CosmoID approach
Miguel Reis Ferreira - Prostate cancer, radiotherapy and gut microbiome
Sandrine Miller Montgomery - Why we need to study tissue microbiome in cancer
Giorgio Trinchieri - Microbiome based strategies in oncology
Nathan Gray - Probiota 2020